Key Points
Nov 8 (Reuters) - The U.S. Food and Drug Administration (FDA) approved the use of a device made by an Otsuka Holdings (4578.T) unit in a type of surgery to treat high blood pressure, the company said on Wednesday...
The device is made by Japanese company Otsuka's unit ReCor and is indicated for use in patients whose hypertension, or high blood pressure, cannot be controlled with drugs...
ReCor's device, which is a balloon-like structure inside a catheter, is inserted through a small cut into the kidney's arteries and sends ultrasound energy to burn nerves that are believed to control blood pressure...
You might be interested in
US FDA approves Medtronic's blood pressure treatment device for use
18, Nov, 23The U.S. Food and Drug Administration on Friday approved the use of Medtronic's (MDT.N) treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by drugs, the company said.
Apellis Pharma's eye-disorder drug gets FDA approval
19, Feb, 23The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals Inc's drug to treat an advanced eye disorder that is one of the leading causes of blindness globally, the company said on Friday.
US regulators inspect Dr Reddy's, other Indian pharma majors
05, Dec, 23The U.S. Food and Drug Administration is inspecting Dr Reddy's (REDY.NS) research and development centre in the southern Indian city of Hyderabad, the pharma company said on Tuesday.
US FDA asks to not purchase certain eye drops due to infection risk
28, Oct, 23The U.S. Food and Drug Administration on Friday issued a warning to consumers to not purchase or use certain eye drops from several major brands due to the risk of eye infection.